Psychiatric Comorbidities in Fibromyalgia: A Comparison With Chronic Conditions and Healthy Controls.
Avni, Chen, Morr, Maya, Sinai, Dana et al. · The Journal of nervous and mental disease · 2025 · DOI
Quick Summary
This study looked at how often mental health conditions like anxiety and depression occur in people with fibromyalgia compared to people with other long-term illnesses and healthy people. Researchers found that fibromyalgia patients had the highest rates of psychiatric conditions overall, with more than half experiencing anxiety and about half experiencing depression. The study suggests that treating fibromyalgia effectively requires addressing both the physical pain and mental health aspects together.
Why It Matters
ME/CFS shares significant clinical overlap with fibromyalgia, including chronic fatigue, widespread pain, and psychiatric comorbidities. This study provides valuable comparative data showing that psychiatric conditions are substantially elevated in fibromyalgia, which has implications for understanding similar patterns in ME/CFS and highlights the importance of integrated mental health care in management strategies. Understanding psychiatric burden across related conditions can inform better screening and treatment approaches for ME/CFS patients.
Observed Findings
Fibromyalgia patients showed the highest prevalence of psychiatric comorbidities compared to other chronic conditions and healthy controls.
Anxiety occurred in 55.1% of fibromyalgia patients and depression in 48.7%.
Fibromyalgia patients had a 34-fold elevated relative risk for Cluster B personality disorders compared to healthy controls.
Fibromyalgia showed a 22.75-fold elevated relative risk for PTSD compared to healthy controls.
Fibromyalgia patients demonstrated extensive psychiatric medication use alongside high psychiatric diagnosis rates.
Inferred Conclusions
Fibromyalgia is associated with a distinctly elevated psychiatric burden that exceeds other chronic pain and inflammatory conditions.
Standard treatment approaches may be insufficient; comprehensive multidisciplinary care addressing both physical and mental health symptoms is necessary.
The elevated risk for personality disorders and PTSD in fibromyalgia suggests distinct psychiatric risk patterns that warrant further investigation.
Integrated psychiatric and medical care should be a standard component of fibromyalgia management.
Remaining Questions
Does the elevated psychiatric comorbidity in fibromyalgia reflect distinct biological mechanisms, or does chronic illness experience account for these associations?
What This Study Does Not Prove
This study does not establish whether psychiatric conditions cause fibromyalgia symptoms, result from living with chronic illness, or reflect shared underlying biological mechanisms—it demonstrates association only. The findings are specific to fibromyalgia and do not directly apply to ME/CFS, despite clinical similarities. Retrospective health care data may not capture all psychiatric diagnoses or reflect true prevalence in the broader population.
Are the personality disorder associations clinically significant diagnoses or artifacts of symptom overlap between fibromyalgia and diagnostic criteria?
How do these psychiatric comorbidity patterns in fibromyalgia compare directly with ME/CFS using identical diagnostic methodologies?
What factors determine which fibromyalgia patients develop psychiatric comorbidities, and could early intervention prevent or reduce psychiatric burden?